Pranaya Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 18.75 Cr
About Pranaya Pharmaceuticals
Pranaya Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 2020 (Four years and ten months 17 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹18.75 Cr.
Satyanarayana Reddy, Sanagala Reddy, Sivaramakrishnareddy Pathuri, and One other member serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG2020PTC139841
-
Company No.
139841
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pranaya Pharmaceuticals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satyanarayana Reddy | Additional Director | 25-Jul-2024 | Current |
Sanagala Reddy | Director | 17-Mar-2020 | Current |
Sivaramakrishnareddy Pathuri | Additional Director | 25-Jul-2024 | Current |
Kumaraswamy Maruri | Director | 22-May-2023 | Current |
Financial Performance of Pranaya Pharmaceuticals.
Pranaya Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pranaya Pharmaceuticals?
In 2021, Pranaya Pharmaceuticals had a public holding of 99.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹18.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 18.75 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
08 Nov 2021 | Indian Bank | ₹18.75 Cr | Open |
How Many Employees Work at Pranaya Pharmaceuticals?
Unlock and access historical data on people associated with Pranaya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranaya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranaya Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.